Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie H. Selim"'
Publikováno v:
Experimental Hematology & Oncology, Vol 8, Iss 1, Pp 1-23 (2019)
Abstract The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal gro
Externí odkaz:
https://doaj.org/article/65502fc9e9dd4aeeaef8e24bb6b30b76
Publikováno v:
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 8, Iss 1, Pp 1-23 (2019)
Experimental Hematology & Oncology, Vol 8, Iss 1, Pp 1-23 (2019)
The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth facto
Publikováno v:
The Annals of pharmacotherapy. 51(10)
Background:Pegfilgrastim should not be given 46 hours. Methods: Single-institution retrospective cohort study of patients who received 5-FUCI administered >46 hours from June 2013 to December 2015. The unit of measurement was chemotherapy cycles. End
Liposome, albumin and polymer polyethylene glycol are nanovector formulations successfully developed for anti-cancer drug delivery. There are significant differences in pharmacokinetics, efficacy and toxicity between pre- and post-nanovector modifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1cc475d8ae3c587fe9a31026e3df18
https://europepmc.org/articles/PMC4988316/
https://europepmc.org/articles/PMC4988316/